PerkinElmer s Acquisition of Packard BioScience Set to Close in November | GenomeWeb

NEW YORK, Oct. 9 – PerkinElmer CEO Gregory L. Summe said on Tuesday that his company is on track to close its proposed acquisition of Packard BioScience in November.

Speaking at the UBS Warburg Global Life Sciences Conference, which runs here through the end of the week, Summe, who is also PerkinElmer’s chairman, said all that remains is a final formal approval by the Securities and Exchange Commission.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.